MDPI and ACS Style
Kojima, M.; Sugimoto, K.; Tanaka, M.; Endo, Y.; Kato, H.; Honda, T.; Furukawa, S.; Nishiyama, H.; Watanabe, T.; Soeda, S.;
et al. Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748. Cancers 2021, 13, 971.
https://doi.org/10.3390/cancers13050971
AMA Style
Kojima M, Sugimoto K, Tanaka M, Endo Y, Kato H, Honda T, Furukawa S, Nishiyama H, Watanabe T, Soeda S,
et al. Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748. Cancers. 2021; 13(5):971.
https://doi.org/10.3390/cancers13050971
Chicago/Turabian Style
Kojima, Manabu, Kotaro Sugimoto, Mizuko Tanaka, Yuta Endo, Hitomi Kato, Tsuyoshi Honda, Shigenori Furukawa, Hiroshi Nishiyama, Takafumi Watanabe, Shu Soeda,
and et al. 2021. "Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748" Cancers 13, no. 5: 971.
https://doi.org/10.3390/cancers13050971